BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 1, 2026
Breaking News: Trump administration impacts continue to roil the life sciences sector
Breaking News: Trump administration impacts continue to roil the life sciences sector
Breaking News: Trump administration impacts continue to roil the life sciences sector
Home
»
Topics
» BioWorld Science, Neurology/psychiatric
BioWorld Science, Neurology/psychiatric
RSS
FDA approves drug/device combination
June 28, 1996
FDA clears Myotrophin early access program
June 28, 1996
MACH discovered by Weizmann Institute
June 28, 1996
Gabitril approved in France as add-on therapy
June 28, 1996
Depakote receives FDA approval for new indication
June 28, 1996
Gensia's GP-3269 in phase I
June 28, 1996
TV-1901 demonstrates efficiency and safety
June 28, 1996
Brain monoamine partial agonists/antagonists claimed by Neurogen
June 28, 1996
DuPont Merck and Richwood enter marketing agreement
June 28, 1996
Fujisawa discloses bradykinin antagonists
June 28, 1996
Previous
1
2
…
2772
2773
2774
2775
2776
2777
2778
2779
2780
…
2797
2798
Next
RSS